GENEVA: The World Health Organization on Friday announced that it has given emergency approval to India-made coronavirus vaccine Kovovax.
jab, produced by Serum Institute of India US-based . under license from novavaxThe vaccine will now be distributed as part of Covax, a global vaccine-sharing system, “a much-needed boost to ongoing efforts to vaccinate more people in low-income countries,” the WHO said in a statement.
“Even as new forms emerge, vaccines are one of the most effective tools to protect people from serious illness and deaths from SARS-CoV-2,” he said. mariangella simao, Access to the WHO’s Head of Vaccines.
“This listing aims to increase access, especially in low-income countries, of which 41 are still unable to vaccinate 10 percent of their population, while 98 countries have not reached 40 percent,” she said.
Kovovax requires two doses and is stable at 2 to 8 °C refrigerated temperatures.
jab, produced by Serum Institute of India US-based . under license from novavaxThe vaccine will now be distributed as part of Covax, a global vaccine-sharing system, “a much-needed boost to ongoing efforts to vaccinate more people in low-income countries,” the WHO said in a statement.
“Even as new forms emerge, vaccines are one of the most effective tools to protect people from serious illness and deaths from SARS-CoV-2,” he said. mariangella simao, Access to the WHO’s Head of Vaccines.
“This listing aims to increase access, especially in low-income countries, of which 41 are still unable to vaccinate 10 percent of their population, while 98 countries have not reached 40 percent,” she said.
Kovovax requires two doses and is stable at 2 to 8 °C refrigerated temperatures.
,